Table 2.
Comparison of initial IV antibiotic treatment (IV) group with the oral antibiotic alone group
| Presentation | IV group | Oral alone |
|---|---|---|
| ESI | 3.44 (3.30–3.57) | 3.59 (3.42–3.77) |
| Tachycardic | 22.1 (13.5–32.6) | 20.3 (13.5–32.6) |
| Febrile | 14.1 (6.2–22.0) | 5.8 (0.1–11.5) |
| Demographics | ||
| Age | 43.1 (39.8–46.4) | 39.1 (36.3–42.0) |
| Female | 46.8 (37.3–56.3) | 48.6 (40.1–57.0) |
| Caucasian | 77.1 (69.1–85.1) | 71.7 (64.1–79.4) |
| Hispanic | 14.7 (7.9–21.4) | 19.6 (12.9–26.3) |
| Black | 7.3 (2.4–12.3) | 8.0 (3.4–12.6) |
| Treatment Target | ||
| Cellulitisa | 46.8 (37.3–56.3) | 25.4 (18.0–32.7) |
| Abscess | 8.3 (3.0–13.5) | 7.2 (2.9–11.6) |
| Dental | 7.3 (2.4–12.3) | 13.8 (7.9–19.6) |
| ENT | 14.7 (7.9–21.4) | 13.0 (7.4–18.7) |
| Respiratory | 4.6 (0.6–8.6) | 7.2 (2.9–11.6) |
| UTIb | 5.5 (1.2–9.9) | 22.5 (15.4–29.5) |
| Prophylaxis | 12.8 (6.5–19.2) | 10.9 (5.6–16.1) |
| Medical history | ||
| Hx diarrhea | 15.6 (8.7–22.5) | 14.5 (8.5–20.4) |
| No disease | 59.6 (50.3–69.0) | 63.0 (54.9–71.2) |
| One disease | 26.6 (18.2–35.0) | 23.9 (16.7–31.1) |
| Two or more | 13.8 (7.2–20.3) | 13.0 (7.4–18.7) |
Means (for ESI and age) and percentages with 95% CIs. Abbreviations: ENT, ear, nose, and throat infection; UTI, urinary tract infection; Hx, history.
a
P = .0005.
b
P= .0002.